J&J (NYSE: JNJ) said to offer hip case accord which may exceed $2B
Johnson & Johnson (NYSE: JNJ) said to offer hip case accord which may exceed $2 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Janssen (JNJ) Announces FDA Approval of Expanded INVOKAMET Indication
- Janssen’s Single-Agent DARZALEX® (daratumumab) Approved by European Commission for Treatment of Multiple Myeloma (MM)
- Sanders may debate Trump, not Clinton, before California contest
Create E-mail Alert Related CategoriesGeneral News, Litigation
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!